Endovastec? Completes First Implantation of Minos? in Malaysia
10 Jun 2025
The Minos? Abdominal Aortic Stent Graft and Delivery System (Minos?), developed by Endovastec?, was recently used in its first post-market implantation in Malaysia.
The procedure was performed on a 78-year-old male patient diagnosed with an abdominal aortic aneurysm complicated by severe calcification. Post-operative results confirmed proper stent positioning and improved blood flow.
Minos? is designed for patients with abdominal aortic aneurysms that have a proximal neck length ≥15 mm. It features a low-profile 14F delivery system with a modular stent structure, offering flexible deployment options for complex anatomies. The device is currently in clinical use across more than 25 countries.
This case further expands Endovastec?’s footprint in Malaysia, following the local adoption of its thoracic aortic solutions, including the Castor? Branched Aortic Stent Graft System. It highlights the company’s ongoing commitment to bringing innovative endovascular solutions to global markets.